Home/ Supplements/ Lycopene/ Vitabasic Senior with Lutein & Lycopene

Vitabasic Senior with Lutein & Lycopene

product on market Tablet or Pill Basic Vitamins Safety: 99/100
99/100

This product looks safe

  • Folate: 667mg is 667.0× the Tolerable Upper Intake Level (1.0mg)
  • 74% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The formulation contains vitamins A, C, D, E, and K, which are supported by strong evidence for maintaining immune function and bone health. These essential nutrients contribute to overall cellular protection and metabolic support in older adults. The profile demonstrates a high safety score, indicating a low risk of adverse effects.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Folate: 667mg is 667.0× the Tolerable Upper Intake Level (1.0mg)

Label

Product Label

Label for Vitabasic Senior with Lutein & Lycopene
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
100
Servings
Other Combinations
Product Type
74%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
750 mcg (83% DV)
Vitamin C
60 mg (67% DV)
25 mcg (125% DV)
1.7× RDA — within safe limits 608 studies (A:16, B:251)
22.5 mg (150% DV)
1.5× RDA — within safe limits 179 studies (A:3, B:90)
30 mcg (25% DV)
Within RDA (0.2× RDA) 275 studies (A:9, B:175)
1.5 mg (125% DV)
1.2× RDA — within safe limits 76 studies (A:0, B:33)
1.7 mg (131% DV)
1.3× RDA — within safe limits 13 studies (A:0, B:1)
20 mg (125% DV)
1.4× RDA — within safe limits 196 studies (A:5, B:63)
3 mg (176% DV)
2.3× RDA — within safe limits 114 studies (A:3, B:35)
667 mcg DFE (167% DV)
Exceeds UL by 667.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
25 mcg (1042% DV)
10.4× RDA — above typical dose 139 studies (A:1, B:44)
30 mcg (100% DV)
Within RDA (1.0× RDA) 27 studies (A:0, B:11)
10 mg (200% DV)
2.0× RDA — within safe limits 2 studies — no high-quality reviews
Calcium
220 mg (17% DV)
20 mg (2% DV)
Market median: 99.0mg (503 products) 13 studies (A:0, B:3)
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
50 mg (12% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
11 mg (100% DV)
Within RDA (1.0× RDA) 263 studies (A:6, B:134)
19 mcg (35% DV)
Within RDA (0.3× RDA) 173 studies (A:0, B:67)
0.5 mg (56% DV)
Within RDA (0.6× RDA) 37 studies (A:0, B:11)
2.3 mg (100% DV)
Within RDA (1.0× RDA) 9 studies — no high-quality reviews
50 mcg (143% DV)
1.4× RDA — within safe limits 199 studies (A:1, B:55)
45 mcg (100% DV)
Within RDA (1.0× RDA) 3 studies — no high-quality reviews
72 mg (3% DV)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
Potassium
80 mg (2% DV)
250 mcg
Market median: 10.0mg (105 products) 2 studies (A:0, B:1)
300 mcg
Market median: 10.0mg (35 products) 6 studies (A:0, B:2)

Other Ingredients

Microcrystalline Cellulose Starch Croscarmellose Sodium Maltodextrin Contains less than 2% of
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Directions: Adults, take one (1) tablet daily preferably with a meal.

Warnings & Precautions

Keep out of the reach of children.

Do not use if inner seal is missing or broken.

Warning: Not intended for use by pregnant or nursing women. If you are taking any medications or planning any medical procedure, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

Formulation Notes

Multivitamin/Multimineral

Iron free/Gluten free

For adults 50+

High quality basics

Gluten free

Additional Information

Store at room temperature.

Metadata

Product Details

DSLD Entry Date2021-06-23
Product TypeOther Combinations
FormTablet or Pill
DSLD ID250027
Data Updated2026-04-11
Research

Research Evidence

8
Research Sources
48
Avg Quality
4
Systematic Review
1
Rct
1
Narrative Review
1
Clinical Trial
B Interventions for the management of oral submucous fibrosis
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
B Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene
Systematic Review European review for medical and pharmacological sciences 2019 PubMed DOI
C Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study)
Rct BJU international 2018 PubMed DOI
C Protective Effects of Micronutrient Supplements, Phytochemicals and Phytochemical-Rich Beverages and Foods Against DNA Damage in Humans: A Systematic Review of Randomized Controlled Trials and Prospective Studies
Systematic Review Advances in nutrition (Bethesda, Md.) 2023 PubMed DOI
C Effectiveness of non-pharmaceutical intervention on sperm quality: a systematic review and network meta-analysis
Systematic Review Aging 2023 PubMed DOI
C Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging
Clinical Trial ClinicalTrials.gov 2018
D Herbal derivatives in the management of mouth opening in oral submucous fibrosis-A network meta-analysis
Narrative Review Oral diseases 2021 PubMed DOI
D Lycopene
View all evidence for Lycopene →
Compare

Similar Products

View all Lycopene products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.